Home > Analytics > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 544222     NSE : AKUMS    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Jan 16,2026
Price(EOD): ₹ 443.95
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 6,987.77 Cr
Value of ₹ 1 Lac invested in AKUMS DRUGS & PHARMACEUTICALS
on Aug 06,2024 (price: ₹ 796.35)

₹ 1 L

₹ 0.56 L

1W : -0.6% 1M : 5.7% 1Y : -27%
COMMUNITY POLL
for AKUMS DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
AKUMS DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
AKUMS DRUGS & PHARMACEUTICALS -0.6% 5.7% -27%
SUN PHARMACEUTICAL INDUSTRIES -3.5% -6.4% -2.6%
DIVIS LABORATORIES -5.8% -1.6% 10.9%
CIPLA -4.7% -6.8% -0.3%
TORRENT PHARMACEUTICALS 1.4% 7% 23.7%
DR REDDYS LABORATORIES -2.8% -8.1% -11.1%
MANKIND PHARMA -1.1% 3.3% -13.4%
ZYDUS LIFESCIENCES -3% -5% -9.3%
LUPIN -0.2% 4.1% 1.9%

FUNDAMENTAL ANALYSIS OF AKUMS DRUGS & PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Sep2025, Y: Mar2025
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF AKUMS DRUGS & PHARMACEUTICALS

 
Valuation Score
[As on : Jan 16,2026 ]

Ratio Consolidated
P/E
P/B
P/S
21.61
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 323.30 Cr
[Latest Qtr - Sep2025 - Consolidated Results ]

2.29
P/B Calculated based on Book Value of Rs 3,047.01 Cr
[Latest Year - Mar2025 - Consolidated Results ]

1.7
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 4,107.52 Cr
[Latest Qtr - Sep2025 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 70% undervalued companies ! Discover More →

FAIR VALUE OF AKUMS DRUGS & PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
19988%
-

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AKUMS DRUGS & PHARMACEUTICALS


Insights 💡 AKUMS is one of the top 38% companies with bullish price momentum currently! Discover More →

AKUMS DRUGS & PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AKUMS DRUGS & PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2025
2024
2023
Avg_3yrs
0
1.57
0.47
0.68
0
0.69
0.75
0.48
[Last Annual Data : Mar2025]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AKUMS DRUGS & PHARMACEUTICALS

Pledged Promoter Shares
0 %
As on : Dec2025

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AKUMS DRUGS & PHARMACEUTICALS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-0.63%
-26.75%
-31.34%
-33.99%
-1.51%
-22.04%
-28.29%
-35.94%
QtrlyTrend
-8
Latest Qtr: Sep2025
Quarterly Result Analysis →


AKUMS DRUGS & PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE SMALLCAP -2.2% -2.7% -5.7%
BSE HEALTHCARE -2.9% -2.5% -2%
NSE Indices1W1M1Y
NIFTY 500 -0.8% -1% 7.7%
NIFTY TOTAL MARKET -0.9% -1.1% 7%
NIFTY500 MULTICAP 50:25:25 -1% -1.1% 5.9%
NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX -1.1% -1.1% 4.7%
NIFTY MIDSMALLCAP 400 -1.2% -1% 4.1%

You may also like the below Video Courses


FAQ about AKUMS DRUGS & PHARMACEUTICALS


Is AKUMS DRUGS & PHARMACEUTICALS good for long term investment?

As on Jan 16,2026, the Fundamentals of AKUMS DRUGS & PHARMACEUTICALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of AKUMS DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AKUMS DRUGS & PHARMACEUTICALS UnderValued or OverValued?

As on Jan 16,2026, AKUMS DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS ?

As on Jan 16,2026, the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS is Rs. 2.21 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -9.02
Fair Value [Median EV / Sales Model] : Rs. 2.21
Fair Value [Median Price / Sales Model] : Rs. 0.00
Estimated Median Fair Value of AKUMS DRUGS & PHARMACEUTICALS : Rs. 2.21

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AKUMS DRUGS & PHARMACEUTICALS trading at a Premium or Discount?

As on Jan 16,2026, AKUMS DRUGS & PHARMACEUTICALS is trading at a Premium of 19967% based on the estimates of Median Intrinsic Value!